Drug Shortage Report for IRINOTECAN HYDROCHLORIDE INJECTION

Last updated on 2024-02-15 History
Report ID 219470
Drug Identification Number 02501295
Brand name IRINOTECAN HYDROCHLORIDE INJECTION
Common or Proper name IRINOTECAN HYDROCHLORIDE INJECTION
Company Name AURO PHARMA INC
Market Status MARKETED
Active Ingredient(s) IRINOTECAN HYDROCHLORIDE
Strength(s) 500MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 25 ml
ATC code L01CE
ATC description
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2024-02-13
Estimated end date
Actual end date 2024-02-14
Shortage status Resolved
Updated date 2024-02-15
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3700 STEELES AVENUE WEST, SUITE 402
WOODBRIDGE, ONTARIO
CANADA L4L 8K8
Company contact information Anahita Rostami

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2024-02-15 English Compare
v6 2024-02-14 French Compare
v5 2024-02-14 English Compare
v4 2024-02-14 English Compare
v3 2024-02-13 French Compare
v2 2024-02-13 English Compare
v1 2024-02-13 English Compare

Showing 1 to 7 of 7